TAM PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
TAM PHARMA
Largest movements
- Receivables within one year +€23,486
up €23,486 (+138.3%), from €16,976 to €40,462
of which Trade receivables: +€24,813
- Cash -€3,920
down €3,920 (-16.1%), from €24,317 to €20,397
mainly Receivables within one year (-€23,486) and Current portion of long-term debt (-€5,936)
- Tangible fixed assets -€1,157
down €1,157 (-35.2%), from €3,282 to €2,126
of which Furniture and vehicles: -€724
- Profit (loss) carried forward +€20,947
up €20,947 (+100.4%), from €20,871 to €41,818
- Tax, wage and social debts +€9,847
up €9,847 (+151.8%), from €6,485 to €16,331
- Current portion of long-term debt -€5,936
no longer reported in 2025 (was €5,936)
- Other debts -€4,495
down €4,495 (-65.6%), from €6,857 to €2,362
- Trade debts -€2,103
down €2,103 (-79.9%), from €2,632 to €529
- Gross operating margin +€12,105
up €12,105 (+71.8%), from €16,866 to €28,971
- Taxes +€2,707
up €2,707 (+74.4%), from €3,641 to €6,348
- Other operating charges -€410
no longer reported in 2025 (was €410)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €44,781 | €63,040 | +€18,260 | +40.8% |
| Fixed assets | 21/28 | €3,337 | €2,181 | -€1,157 | -34.7% |
| Tangible fixed assets | 22/27 | €3,282 | €2,126 | -€1,157 | -35.2% |
| Plant, machinery and equipment | 23 | €799 | €367 | -€433 | -54.1% |
| Furniture and vehicles | 24 | €2,483 | €1,759 | -€724 | -29.2% |
| Financial fixed assets | 28 | €55 | €55 | = | 0.0% |
| Current assets | 29/58 | €41,443 | €60,859 | +€19,416 | +46.9% |
| Amounts receivable within one year | 40/41 | €16,976 | €40,462 | +€23,486 | +138.3% |
| Trade receivables | 40 | €15,649 | €40,462 | +€24,813 | +158.6% |
| Other amounts receivable | 41 | €1,327 | - | -€1,327 | |
| Cash at bank and in hand | 54/58 | €24,317 | €20,397 | -€3,920 | -16.1% |
| Deferred charges and accrued income | 490/1 | €150 | - | -€150 | |
| Total equity and liabilities | 10/49 | €44,781 | €63,040 | +€18,260 | +40.8% |
| Equity | 10/15 | €22,871 | €43,818 | +€20,947 | +91.6% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €20,871 | €41,818 | +€20,947 | +100.4% |
| Amounts payable | 17/49 | €21,909 | €19,222 | -€2,687 | -12.3% |
| Amounts payable within one year | 42/48 | €21,909 | €19,222 | -€2,687 | -12.3% |
| Current portion of amounts payable after more than one year | 42 | €5,936 | - | -€5,936 | |
| Trade debts | 44 | €2,632 | €529 | -€2,103 | -79.9% |
| Suppliers | 440/4 | €2,632 | €529 | -€2,103 | -79.9% |
| Taxes, remuneration and social security | 45 | €6,485 | €16,331 | +€9,847 | +151.8% |
| Taxes | 450/3 | €6,485 | €16,331 | +€9,847 | +151.8% |
| Other amounts payable | 47/48 | €6,857 | €2,362 | -€4,495 | -65.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,364 | €1,157 | -€207 | -15.2% |
| Other operating charges | 640/8 | €410 | - | -€410 | |
| Gross operating margin | 9900 | €16,866 | €28,971 | +€12,105 | +71.8% |
| Operating profit (loss) | 9901 | €15,092 | €27,814 | +€12,722 | +84.3% |
| Financial income | 75/76B | €0 | €23 | +€23 | +115350.0% |
| Recurring financial income | 75 | €0 | €23 | +€23 | +115350.0% |
| Financial charges | 65/66B | €760 | €542 | -€219 | -28.7% |
| Recurring financial charges | 65 | €760 | €542 | -€219 | -28.7% |
| Profit (loss) for the period before taxes | 9903 | €14,332 | €27,296 | +€12,964 | +90.5% |
| Income taxes | 67/77 | €3,641 | €6,348 | +€2,707 | +74.4% |
| Profit (loss) for the period | 9904 | €10,691 | €20,947 | +€10,256 | +95.9% |
| Profit (loss) for the period to be appropriated | 9905 | €10,691 | €20,947 | +€10,256 | +95.9% |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.